naloxone

BioPharma, Pharma

In 2016, the opioid epidemic hit home

In February of this year, the FDA approved the Narcan nasal spray to revive patients that had overdosed on opioid drugs. But the real story of 2016 was how widely that antidote was needed. The epidemic reached all corners of America in deadly new synthetic forms, raising unprecedented awareness about the dangers of opioid use -- without yet bringing the death toll down.